Drug lobby taps Biden aide's brother

• Lobbying revenue for Ricchetti Inc., Jeff's firm, more than quadrupled over the past two years as it signed a number of blue-chip clients.
• He's one of a number of Biden-connected lobbyists seeing huge growth under unified Democratic control in D.C., Politico reported on Wednesday.

The details: Ricchetti has been lobbying for PhRMA since Jan. 1, according to a disclosure filing with congressional ethics officials on Wednesday.

• He's has been working on "issues related to pharmaceutical industry, generally."
• The firm got $60,000 for that work in the first three months of the year, but didn't report contacting any federal agencies or members of Congress.
• Its client roster includes a number of other pharmaceutical and biotechnology companies, disclosure records show.

Between the lines: Steve Ricchetti is a counselor to President Biden, and has been instrumental to the White House's legislative efforts.

• Biden has renewed a push this year to let Medicare negotiate drug prices, a measure strongly opposed by the pharmaceutical industry.
• The White House declined to comment.

What they're saying: "While we generally don’t comment on specific firms," a PhRMA spokesperson told Axios, "we work with a diverse group of advocacy partners to help promote policies that support innovation and affordable access to life-saving medicines.”